SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)

Market Cap	3.57B
Revenue (ttm)	954.68M
Net Income (ttm)	134.17M
Shares Out	150.61M
EPS (ttm)	0.89
PE Ratio	26.67
Forward PE	21.76
Dividend	0.16 (0.69%)
Ex-Dividend Date	Feb 5, 2025

Volume	74,937
Average Volume	74,306
Open	23.10
Previous Close	23.10
Day's Range	23.10 - 23.10
52-Week Range	22.22 - 43.40
Beta	n/a
RSI	46.99
Earnings Date	Feb 13, 2025

About ETR:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide. The company offers prefillable glass or polymer syringes, glass vials, cartridges, and ampoules. Its syringe products include syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPA...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1884
• Employees: 4,690
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: 1SXP

Financial Performance

In 2024, ETR:1SXP's revenue was 957.09 million, an increase of 6.51% compared to the previous year's 898.60 million. Earnings were 149.69 million, a decrease of -1.42%.